Photodynamic therapy with photofrin reduces invasiveness of malignant human glioma cells

Lasers Med Sci. 2002;17(4):280-8. doi: 10.1007/s101030200041.

Abstract

In this study we investigated the influence of Photofrin-based photodynamic therapy (PDT) on the migration of two human glioma cell lines in vitro. U87 and U25ln tumour cells were treated with Photofrin at various doses and subjected to a fixed optical (632 nm) dose of 100 mJ/cm(2). Photofrin cytotoxicity was determined using MTT and colony forming assays. Using a matrigel artificial basement membrane migration assay, we demonstrated that low doses of subcytotoxic PDT treatment, such as PDT with 2.5 micro g/ml Photofrin on U87 cells and 1 micro g/ml on U25ln cells, significantly ( p<0.001) inhibited in vitro migration of both cell lines. Furthermore, in a qualitative spheroid confrontation assay, subcytotoxic PDT of co-cultures between tumour spheroids and brain aggregates resulted in an absence of progressive tumour invasion and destruction of the brain aggregate. In conclusion, our data indicate that low-dose subcytotoxic PDT with Photofrin significantly inhibits invasiveness of U87 and U25ln cells.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / pathology
  • Coculture Techniques
  • Dihematoporphyrin Ether / administration & dosage*
  • Glioma / drug therapy*
  • Glioma / pathology
  • Humans
  • Microscopy, Confocal
  • Photochemotherapy*
  • Photosensitizing Agents / administration & dosage*
  • Rats
  • Spheroids, Cellular / drug effects
  • Tumor Cells, Cultured

Substances

  • Photosensitizing Agents
  • Dihematoporphyrin Ether